Minimal Residual Disease (MRD) at Time of Complete Remission Is Commonly Detected in Acute Myeloid Leukemia (AML) Patients Age ≥60 Years and Significantly Impacts Outcome Based on Post-Remission Treatment Strategies: Prospective Analysis of ECOG-ACRIN (E-A) E2906 Phase III Trial

James M Foran,Mark R Litzow,Janis Racevskis,Yanming Zhang,Zhuoxin Sun,Martin S Tallman,Daniel A Arber,Jacob M Rowe,John Godwin,Elisabeth Paietta,Jessica K Altman,Bayard L Powell,Hong Zheng,David F Claxton,Keith W Pratz,Selina M Luger ,E Randolph Broun ,Hillard M Lazarus ,Kristen M O’dwyer ,Aref Al‐Kali

doi:10.1182/blood-2018-99-113950

Minimal Residual Disease (MRD) at Time of Complete Remission Is Commonly Detected in Acute Myeloid Leukemia (AML) Patients Age ≥60 Years and Significantly Impacts Outcome Based on Post-Remission Treatment Strategies: Prospective Analysis of ECOG-ACRIN (E-A) E2906 Phase III Trial

James M Foran, Mark R Litzow + Show 18 more

Open Access

https://doi.org/10.1182/blood-2018-99-113950

Copy DOI

Journal: Blood	Publication Date: Nov 29, 2018
Citations: 4

Affiliation: Jacksonville College, Mayo Clinic, Montefiore Medical Center, Memorial Sloan Kettering Cancer Center, ECOG-ACRIN Cancer Research Group, University of Chicago, Shaare Zedek Medical Center, Providence Portland Medical Center, Northwestern University, Atrium Health Wake Forest Baptist, Penn State Milton S. Hershey Medical Center, Johns Hopkins University, University of Pennsylvania, Oncology Hematology Care, University Hospitals Seidman Cancer Center, University of Rochester Medical Center

#Minimal Residual Disease #Research Funding + Show 8 more

Abstract
Full-Text
Similar Papers

Abstract

Minimal Residual Disease (MRD) at Time of Complete Remission Is Commonly Detected in Acute Myeloid Leukemia (AML) Patients Age ≥60 Years and Significantly Impacts Outcome Based on Post-Remission Treatment Strategies: Prospective Analysis of ECOG-ACRIN (E-A) E2906 Phase III Trial

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Blood

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.